Samarth Kulkarni Sells 19,582 Shares of CRISPR Therapeutics AG (NASDAQ:CRSP) Stock
CRISPR Therapeutics AG (NASDAQ:CRSP – Get Free Report) CEO Samarth Kulkarni sold 19,582 shares of the stock in a transaction on Monday, April 15th. The stock was sold at an average price of $59.91, for a total value of $1,173,157.62. Following the completion of the sale, the chief executive officer now directly owns 208,122 shares […]
More Stories
Gold Prices Surge to Highest Level in Over 3 Months
By Naveen Athrappully Gold prices are trading at their highest level in more than three months on Monday, amid continued...
Treasury, IRS Propose Rules on Trump Account Investments
By Naveen Athrappully The Department of the Treasury and the IRS have issued proposed regulations clarifying which investments may be...
Iryna Zarutska’s Family Sues City of Charlotte Over Fatal Rail Stabbing, Blaming Security Failures
By Owen Evans The family of 23-year-old Ukrainian refugee Iryna Zarutska, who was stabbed to death in North Carolina, has...
IndyCar Race Caps Summer Events for America’s 250th Birthday
By Travis Gillmore WASHINGTON—More than 100,000 spectators lined the streets to witness history as drivers raced by national monuments on...
Zelenskyy Rejects Calls for Wartime Elections in Ukraine
By Tom Gantert Ukrainian President Volodymyr Zelenskyy said holding elections during the war with Russia would “destroy the country,” in...
DOJ Says Diplomat Discipline Board Can’t Overrule Secretary of State
By Matthew Vadum A Department of Justice (DOJ) body held that an independent board that reviews disciplinary actions against U.S....